Current filters:


Popular Filters

6776 to 6800 of 6825 results

Anti-inflammatory drugs reduce effectiveness of SSRI antidepressants


Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, USA,…


Drug developers actively improving efficiency of clinical trials, says Tufts CSDD


Looking to improve the operational efficiency of clinical trials, drug developers are actively pursuing…


Aoxing gains GMP certification from China’s SFDA


New York, USA-based specialty drug group Aoxing Pharmaceutical (NYSE Amex: AXN) said yesterday that its…

Aoxing PharmaceuticalAsia-PacificHebei AoxingPharmaceuticalRegulation

Patient death linked to Pfizer’s RA drug candidate tofacitinib


Global drugs behemoth Pfizer (NYSE: PFE) saw its share drop 3,6% to $19.67 after the company commented…


Daiichi Sankyo gains first approval for VTE drug Lixiana, in Japan


Japanese drug major Daiichi Sankyo (TYO: 4568) has received its first marketing approval for Lixiana…

Asia-PacificCardio-vascularDaiichi SankyoLixianaPharmaceuticalRegulation

CSL Behring gets European OK for Hizentra


Germany-based CSL Behring says that the European Commission has granted marketing authorization for Hizentra…

CSL BehringCSL LimitedEuropeHizentraImmunologicalsPharmaceuticalRegulation

AstraZeneca debuts vandetanib for medullary thyroid cancer in USA


Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that its orphan drug vandetanib is now…

AstraZenecaMarkets & MarketingNorth AmericaOncologyPharmaceuticalRare diseasesvandetanibZactima

Mexico and the second medical use claims in the new European format for patents


Therapeutic treatment methods for humans or animals are excluded from patentability under most legal…

EuropePatentsPharmaceuticalSouth America

Two new studies find Bayer's contraceptives Yaz and Yasmin have an increased risk of blood clots


According to two new studies published in the on-line edition of the British Medical Journal, German…


Vaccine to halt Alzheimer's could be available within few years


A vaccine that has the potential to stop Alzheimer's disease progression could be available within a…

BiotechnologyCytos BiotechnologyNeurologicalNovartisPharmaceuticalResearchVaccines

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line


Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

SciClone buys NovaMed, expanding presence in China for up to $105 million


USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) says that it has acquired NovaMed Pharmaceuticals,…

Asia-PacificFinancialMergers & AcquisitionsNovaMed PharmaPharmaceuticalSciClone Pharma

Roche gets FDA OK for use of Rituxan to treat two rare disorders


The US Food and Drug Administration yesterday approved Swiss drug major Roche (ROG: SIX) subsidiary Genentech’s…

North AmericaPharmaceuticalRare diseasesRegulationRituxanRoche

Abbott Labs 1st-qtr 2011 sales jump 17% but profits down 14% on acquisitions and restructuring


US health care major Abbott Laboratories (NYSE: ABT) reported financial results for the first quarter…

Abbott LaboratoriesFinancialPharmaceutical

Pfizer views China opportunities, signing MoU with Shanghai Pharma


Global drugs behemoth Pfizer (NYSE: PFE) has signed a memorandum of understanding (MOU) with Shanghai…

Asia-PacificLicensingPfizerPharmaceuticalPrevenarShanghai Pharmaceutical Group

Forest Labs FY 4th-qtr beats forecasts; in-licenses antiarrhythmic


US drugmaker Forest Laboratories (NYSE: FRX) reported that, for its fiscal fourth quarter ended March…

azimilideCardio-vascularFinancialForest LaboratoriesLicensingPharmaceutical

Transgene, ChronTech Pharma and Inovio to collaborate on hep C vaccine


France’s Transgene (Euronext Paris: FR0005175080) has signed a collaboration agreement with Sweden’s…

Anti-viralsChronTech PharmaInovio PharmaceuticalsPharmaceuticalResearchTransgeneVaccines

ARIAD in three exclusive out-licensing deals for ARGENT cell-signaling regulation technology


USA-based ARIAD Pharmaceuticals (Nasdaq: ARIA) has announced execution of three exclusive out-license…

Ariad PharmaceuticalsLicensingPharmaceuticalResearch

Johnson & Johnson 1st-qtr 2011 beats forecasts despite 23% profits slump and consumer recall woes


US diversified health care giant Johnson & Johnson (NYSE: JNJ) announced sales of $16.2 billion for the…

FinancialJohnson & JohnsonPharmaceutical

Baxter to acquire Prism Pharmaceuticals for up to $338 million


With the aim of expanding its drug delivery offerings, USA-based drugs and medical device maker Baxter…

BaxterCardio-vascularMergers & AcquisitionsNexteronePharmaceuticalPrism Pharmaceuticals

6776 to 6800 of 6825 results

Back to top